Clinical Course of Nodular Regenerative Hyperplasia in Thiopurine Treated Inflammatory Bowel Disease Patients

Autor: Dewkoemar Ramsoekh, Melek Simsek, Sybrand Y. De Boer, Berrie Meijer, Jeroen M. Jansen, Marc A. M. T. Verhagen, Nanne K. H. de Boer, Toos Steinhauser, Dutch Initiative on Crohn, Frank Hoentjen, Bert den Hartog, Colitis (Icc), Gerard Dijkstra, Annemarie C. de Vries, Menno A. Brink, Egbert-Jan van der Wouden, Bas Oldenburg, Chris J. J. Mulder, Gerd Bouma, Ton H Naber, Ruud Beukers, Lennard P L Gilissen, Andrea Van Der Meulen

Publikováno v: Clinical Gastroenterology and Hepatology, 17(3), 568-570. ELSEVIER SCIENCE INC
Simsek, M, Meijer, B, Ramsoekh, D, Bouma, G, van der Wouden, E-J, den Hartog, B, de Vries, A C, Hoentjen, F, Dijkstra, G, de Boer, S Y, Jansen, J M, van der Meulen, A E, Beukers, R, Brink, M A, Steinhauser, T, Oldenburg, B, Gilissen, L P, Naber, T H, Verhagen, M A, de Boer, N K H, Mulder, C J J & Dutch Initiative on Crohn and Colitis (ICC) 2019, ' Clinical Course of Nodular Regenerative Hyperplasia in Thiopurine Treated Inflammatory Bowel Disease Patients ', Clinical Gastroenterology and Hepatology, vol. 17, no. 3, pp. 568-570 . https://doi.org/10.1016/j.cgh.2018.05.009
Clinical Gastroenterology and Hepatology, 17(3), 568. W.B. Saunders Ltd
Clinical Gastroenterology and Hepatology, 17, 3, pp. 568-570
Clinical Gastroenterology and Hepatology, 17, 568-570
Clinical Gastroenterology and Hepatology, 17(3), 568-570
Clinical Gastroenterology and Hepatology, 17(3), 568-570. W.B. Saunders

Item does not contain fulltext Nodular regenerative hyperplasia (NRH) is a poorly understood liver condition, which is increasingly recognized in thiopurine-treated patients with inflammatory bowel disease (IBD).(1) It is difficult to establish an op

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50904fa7f0690a31e7ca073e88b824ea
https://doi.org/10.1016/j.cgh.2018.05.009